Canadian Adverse Health Events from COVID-19 Vaccines and COVID-19 Statistics – April 29, 2021

 

Author: Tracey Young. (April 29, 2021). Canadian Adverse Health Events from COVID-19 Vaccines and COVID-19 Statistics – April 29, 2021. Canadian Advocacy Centre for Health, Safety and Justice. Retrieved from: https://canadianadvocacycentre.blogspot.com/2021/04/canadian-adverse-health-events-from_30.html.

Introduction

COVID-19 Vaccines have been getting administered in Canada since December 2020. Around the world countries are reporting a staggering range of post-vaccine Adverse Health events, and deaths associated with all of the COVID-19 vaccines that have received Interim, or Emergency authorization in their respective countries. 

The Canadian government has reported 38 deaths have occurred after COVID19 vaccines were administered in Canada. Upon further medical investigation and review, the Canadian government reported 19 deaths were not associated with the COVID-19 vaccine. They have also reported 19 of these deaths continue to be under investigation. Anecdotal reports of post-vaccine deaths are being reported across Canada. Official statistical data being reported in Canada does not appear to be capturing all of the post-vaccine AEFI's, or mortalities. 

In this article I will provide an overview of Canadian government statistical data and information about Adverse Events Following Immunization (AEFI) with COVID-19 vaccines, vaccine injuries and reactions that have been associated with these vaccines up to April 16th, 2021. 

Figure 4. Most frequently reported adverse events up to and including April 16, 2021 (n=10,925)

Canada: COVID Vaccines: Adverse Events Following Immunization (AEFI) Statistical Data and Information

COVID-19 Vaccine Safety - Government of Canada

Source: https://health-infobase.canada.ca/covid-19/vaccine-safety/

Adverse Events Following Immunization (AEFI) Statistical Data

Dates: From mid-December 2020 – April 16^th, 2021

Note: Detailed AEFI Breakdowns can be found under Figure 4 (scroll down to the bottom of the page and click on the link).

⮚ COVD Vaccine Doses Administered in Canada: 9,525,732

• Previous: Feb. 12th: 1,221,539; Feb. 19th: 1,402,139; Feb. 26th:1,778,405; March 5th: 2,255,174; March 12th: 2,830,164; March 19th: 3,729,312; March 26th: 4,800,931; April 2nd: 5,897,445; April 9th: 7,569,321

⮚ 3,738 AEFI’s (.039% of all doses administered); 

• Previous: Feb. 12th: 957; Feb. 19th: 1235; ; Feb. 26th:1591; March 5th: 1923; March 12th: 1922; ; March 19th: 2,530; March 26th: 2,859; April 2nd: 3,089; April 9th: 3,444

⮚ 38 Deaths 

• 19 reported to not be linked to vaccine; 19 are still under investigation
• Previous: March 26th: 24 (13 not linked; 15 under investigation); April 2nd: 27 (16 reported to not be linked to vaccine; 11 are still under investigation); April 9th: 31

⮚ 529 Serious AEFI’s (.006% of all doses administered); 6.1 reports per 100,000 doses administered.

• Previous: Feb. 12th: 140; Feb. 19th: 167; Feb. 26th:194; ; March 5th: 214; March 12th: 287; March 19th: 320; March 26th: 384; April 2nd: 421; April 9th: 464

⮚ 3,209 Non-serious AEFI’s (.034% of all doses administered); 

• Previous: Feb. 12th: 817Feb. 19th:1068; Feb. 26th:1397; ; March 5th:1709; March 12th:1922; March 19th: 2,210; March 26th: 2,475; April 2nd: 2,668; April 9th: 2,980

⮚ 158 New Adverse events reported in the last week

• Previous: March 26th: 247; April 2nd:182; April 9th: 138

⮚ # of reported adverse events was highest among females and those aged 18 to 49.

⮚ 39.2 reports per 100,000 doses administered (out of a total of 3,738 reports) up to and including April 16, 2021.

Figure 1. Cumulative number of adverse event reports and total doses administered 

per week up to and including April 16, 2021 (n=3,758*)

Definition of Serious AEFI:

An event is considered serious if it:

• results in death
• is life-threatening (an event/reaction in which the patient was at real, rather than hypothetical, risk of death at the time of the event/reaction)
• requires in-patient hospitalization or prolongation of existing hospitalization
• results in persistent or significant disability/incapacity, or
• results in a congenital anomaly/birth defect

Anaphylaxis: Among the 529 serious reports, the most frequently reported adverse event was anaphylaxis.

Special Note Regarding Blood Clots from COVID-19 vaccine: There have been reports in Europe of blood clots associated with low levels of blood platelets (thrombocytopenia) following vaccination with the AstraZeneca COVID-19 vaccine. 

⮚ There have been reports around the world of blood clots associated with different COVID-19 vaccines. In Canada, there have been three reports of Thrombosis with Thrombocytopenia Syndrome following vaccination with COVISHIELD in Canada.

Source: Government of Canada. (April 29, 2021). Coronavirus Disease (COVID-19) Epidemiology Update. Retrieved from: https://health-infobase.canada.ca/covid-19/vaccine-safety/. 

Canadian COVID-19 Statistics: April 29, 2021

➤ 3% of Canadians have been diagnosed with COVID-19 in 1+ year

➤️.2% Active cases in the Canadian population

➤ 91% Recovered 

➤ 5% hospitalization rate

➤ ️4% rate of positive of 31+ million Canadians tested

➤️ .06% of Canadian population have been reported to die with COVID-19

➤ 96% of those who have died with CV-19 were over 60 years old, with pre-existing health conditions that are associated with more severe cases

Figure 3. Adverse event reports by age group up to and including April 16, 2021

Miscellaneous COVID-19 Vaccine Data

Front line Worker Testimonies: COVID-19 Vaccine Adverse Reactions. Retrieved from: https://drive.google.com/file/d/1YK0JR_lFy88Zu3rcC3L5NvL_Xr3ib6zY/view.

Copyright © 2021.Tracey Young/Canadian Advocacy Centre for Health, Safety and Justice. All Rights Reserved.
_________________________________________________

#COVID19 #COVID19Canada #COVIDvaccines #COVID19vaccines #Canada #DutytoWarn #HealthPromotion #HealthPrevention #InformedConsent #cdnpoli #canpoli